Interpretation of arrhythmogenic effects of COVID-19 disease through ECG

Ozturk F., Karaduman M., Coldur R., İncecik Ş., Gunes Y., Tuncer M.

AGING MALE, cilt.23, sa.5, ss.1362-1365, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 5
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1080/13685538.2020.1769058
  • Dergi Adı: AGING MALE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Abstracts in Social Gerontology, AgeLine, CINAHL, EMBASE, MEDLINE, SportDiscus
  • Sayfa Sayıları: ss.1362-1365
  • Anahtar Kelimeler: Malignant arrhythmia, COVID-19, QT prolongation, ECG, INTERVAL, RISK, TEND
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Objective: We aimed to detect the malignant arrhythmic potential of COVID-19 with surface electrocardiographic (ECG) markers. Material and method:Of the ECG parameters PR, QT, QTc, QTd, TPe, and Tpe/QTc were measured in 51 COVID-19 patients and 40 in control subjects. Results: Compared to control group mean QTc (410.8 +/- 24.3 msec vs. 394.6 +/- 20.3 msec,p < .001) and Tpe/QTc (0.19 +/- 0.02 vs. 0.18 +/- 0.04,p= .036) and median QTd (47.52 vs. 46.5) values were significantly higher in COVID-19 patients. Troponin levels were significantly correlated with heart rate (r = 0.387,p = .006) but not with ECG parameters. Conclusion:Several ventricular arrhythmia surface ECG predictors including QTc, QTd, and Tpe/QTc are increased in COVID-19 patients. Since medications used in COVID-19 patients have the potential to affect these parameters, giving importance to these ECG markers may have a significant contribution in decreasing disease-related arrhythmias.